Concepedia

Nikolaos Tsesmetzis

NT

5

Publications

220

Citations

5

H-Index

2018

Active since

Affiliations

Karolinska Institutet(Current)

Karolinska University Hospital

Emory University

Uppsala University

Heidelberg University

Nikolaos Tsesmetzis is an author at Karolinska Institutet specializing in tumor biology, cancer research, and drug discovery.

Top concepts

Publications per year

2018–2024

5

Publications

5

STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer

Ioannis Zerdes, Majken Wallerius, Emmanouil G. Sifakis et al. · Cancers · 2019 · 93 citations · Full text

Ribonucleotide reductase inhibitors suppress <scp>SAMHD</scp> 1 ara‐ <scp>CTP</scp> ase activity enhancing cytarabine efficacy

Sean G. Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv et al. · EMBO Molecular Medicine · 2020 · 57 citations · Full text

, , +18

Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens

George Z. Rassidakis, Nikolas Herold, Ida Hed Myrberg et al. · Blood Cancer Journal · 2018 · 42 citations · Full text

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial

Martin Jädersten, Ingrid Lilienthal, Nikolaos Tsesmetzis et al. · Journal of Internal Medicine · 2022 · 17 citations · Full text

SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma

Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord et al. · Blood · 2024 · 11 citations · Full text

Rows per page

1–5 of 5